Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 4,813 | 4,508 | 3,632 | 4,571 | 4,339 |
| Operating Income | -4,813 | -4,508 | -3,632 | -4,571 | -4,339 |
| Other Income | 1,015 | 134 | 2,411 | 530 | 1,559 |
| Pre-tax Income | -3,798 | -4,374 | -1,221 | -4,041 | -2,780 |
| Income Tax | N/A | -229 | N/A | N/A | N/A |
| Net Income Continuous | -3,798 | -4,145 | -1,221 | -4,041 | -2,780 |
| Net Income | $-3,798 | $-4,145 | $-1,221 | $-4,041 | $-2,786 |
| EPS Basic Total Ops | -146.29 | -202.36 | -67.45 | -314.78 | -224.84 |
| EPS Basic Continuous Ops | -146.90 | -204.99 | -64.76 | -312.61 | -228.90 |
| EPS Diluted Total Ops | -146.29 | -202.36 | -67.45 | -314.78 | -224.84 |
| EPS Diluted Continuous Ops | -146.90 | -204.99 | -64.76 | -312.61 | -228.90 |
| EBITDA(a) | $-4,761 | $-4,458 | $-3,583 | $-4,523 | $-4,298 |